[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:systemic-lupus-erythematosus:rf":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Systemic Lupus Erythematosus","RF",3,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07201558","Study Evaluating Safety, Tolerability, PK\u002FPD of Surovatamig in Adult RA or SLE Participants",[12],"Phase 1","RECRUITING","2026-08-26T02:17:36.611194Z","2026-07-05T05:32:16.666464Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06916806","A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.",[12],"2026-08-26T02:18:01.700186Z","2026-05-05T02:43:28.362747Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT07607964","A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)",[12],"2026-08-26T02:17:42.501124Z","2026-05-29T15:36:40.226566Z"]